Following the steps of its CEO in denunciating Covid-19 vaccine “misinformation,” pharma giant Pfizer tweeted a cartoon meme about science protecting humanity from wild conspiracy theories along with the hashtag #ScienceWillWin.
Pfizer’s corporate account tweeted on Tuesday evening a cartoon that shows a blob labeled “science” trying to stop a humanoid figure from embracing a “wild conspiracy theories” bubble along with the message “It’s easy to get distracted by misinformation these days, but don’t worry… Science has got your back.”
Although the reply option on the post was disabled, that didn’t stop over 3,000 people rationing the tweet to quote-tweet within less than two hours compared to only just 300 likes.
Responding with his own version of the meme, filmmaker Mike Cernovich pointed that the US drug-maker, which denies science, obtained a legal waiver of responsibility so no one harmed by Pfizer’s vaccines can sue it.
Human Events editor Jack Posobiec, on the other hand, stressed that Big Pharma can’t meme.
Pfizer’s CEO Albert Bourla said shortly before that “misinformation” about Covid-19 vaccines, including the Pfizer-made mRNA jabs is spread by a “very small” group of people who spread, on purpose, misinformation to mislead those that have concerns with the vaccine.
He called those people criminals because ‘they have literally cost millions of lives’.
Addressing the NATO-backed Atlantic Council think tank, Bourla pointed that it’s hesitancy to vaccinations that stands between the new way of life and the current way of life.
Since the onset of the COVID-19 pandemic, social media platforms have been swarmed with misinformation, undermining the science behind the vaccines and the coronavirus itself.
Though YouTube cracked down on misinformation and banned anti-vaccine content in September, the Center for Countering Digital Hate’s report shows that a group of anti-vaxxers called the “Disinformation Dozen, who play leading roles in spreading vaccine misinformation online, are still spreading misinformation on the platform.
Be the first to comment